1) pseudoephedrine in plasma
伪麻黄碱血药浓度
2) pseudoephedrine
[英][,su:dəʊɪ'fedrɪn, -'efɪ,dri:n] [美][,sudoɪ'fɛdrɪn, -'ɛfɪ,drin]
伪麻黄碱
1.
The Ephedrine and Pseudoephedrine Separation with the Capillary Electrophoresis and Determination by Conductivity Detector;
高效毛细管电泳分离/电导检测麻黄碱和伪麻黄碱
2.
Determination of Pseudoephedrine in Human Plasma Using Capillary Zone Electrophoresis Coupled by Flow Injection on line Solid Phase Extraction;
流动注射在线固相萃取预富集毛细管区带电泳测定血浆中的伪麻黄碱
3.
Study of Chiral Separation of Pseudoephedrine by High-Performance Capillary Zone Electrophoresis;
高效毛细管电泳法手性分离伪麻黄碱
3) ephedrine
[英]['efidri:n] [美]['ɛfədrin]
伪麻黄碱
1.
Research on Stereoselectivity of Pseudoephedrine in Pseudoephedrine Cetirizine Sustained-Release Tablets in Vivo;
西嗪伪麻缓释片中伪麻黄碱在人体内的立体选择性研究
2.
The stereoselective synthesis of oxazolidine derivatives was accomplished,starting from ephedrine,pseudo-ephedrine and substituted benzaldehyde.
WZZ 2A自动旋光仪,溶剂为无水乙醇(17℃),麻黄碱和伪麻黄碱由宁夏永宁制药厂提供,其余试剂均为分析纯。
3.
Nine diastereomeric oxazolidine derived from epheolrine or pseudo-ephedrine have been reported.
分别以麻黄碱和伪麻黄碱为原料通过简便的方法,立体选择性的合成了9种恶唑烷类化合物,并根据其波谱数据确定了他们的结构和构型,分析了非对映异构体的光谱特征。
4) pseudo-ephedrine
伪麻黄碱
1.
Effect on pharmacokinetics of pseudo-ephedrine in human plasma among herbs in Mahuang decoction;
麻黄汤中臣佐使药对君药中伪麻黄碱的人体药代学的影响
2.
Results: The dose-dependent inotropic effect elicited by pseudo-ephedrine (10 -6～1×10 -4mol/L) on guinea-pig atria was not affected by phentolamine pretreatment; pseudo-ephedrine-induced dose-dependent (10 -6～3×10 -4mol/L) contractility of rat s anococcygeus muscles was inhibited by yohimbine (10 -6mol/L) and prazosin(10 -7mol/L)pretr.
目的 :研究伪麻黄碱 (p-Eph)对肾上腺素α受体的作用。
3.
Objective:To study the actions of pseudo-ephedrine and ephedrine on isolated rabbit s and rat s aorta ring.
目的 :研究伪麻黄碱和麻黄碱对主动脉的作用。
5) ephedrine、d-pseudo-ephedrine
麻黄碱、伪麻黄碱
补充资料：N-乙酰基去甲伪麻黄碱
分子式：C11H15NO2
分子量：193.25
CAS号：3708-33-6
性质：结晶。熔点74-76℃。[α]25/D-8.5（无水乙醇）。
制备方法：用去甲伪麻黄碱以乙酸酐酰化制得。
用途：冠脉扩张剂奥昔非君的中间体。
分子量：193.25
CAS号：3708-33-6
性质：结晶。熔点74-76℃。[α]25/D-8.5（无水乙醇）。
制备方法：用去甲伪麻黄碱以乙酸酐酰化制得。
用途：冠脉扩张剂奥昔非君的中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条